These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3888822)

  • 41. Trichomonas vaginalis Infection in a Tertiary Care Vaginitis Center.
    Keating MA; Nyirjesy P
    Sex Transm Dis; 2015 Sep; 42(9):482-5. PubMed ID: 26267873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival of Trichomonas vaginalis in human semen.
    Daly JJ; Sherman JK; Green L; Hostetler TL
    Genitourin Med; 1989 Apr; 65(2):106-8. PubMed ID: 2787774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Investigation of Trichomonas vaginalis in patients with nonspecific vaginal discharge].
    Akarsu GA
    Turkiye Parazitol Derg; 2006; 30(1):19-21. PubMed ID: 17106848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of Trichomonas vaginalis infection in and around Surat.
    Chakraborty T; Mulla SA; Kosambiya JK; Desai VK
    Indian J Pathol Microbiol; 2005 Oct; 48(4):542-5. PubMed ID: 16366122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The clinical significance of Trichomonas vaginalis infection in male urogenital organs].
    Ohkawa M; Nakashima T; Tokunaga S; Shimamura M; Sugata T; Hisazumi H
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):706-13. PubMed ID: 3499538
    [No Abstract]   [Full Text] [Related]  

  • 46. [Vaginal trichomoniasis. Diagnostic methods and examination results].
    Bartunek J; Schultze M
    Hautarzt; 1972 Aug; 23(8):368-70. PubMed ID: 4565158
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
    Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
    Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of four diagnostic techniques for detection of Trichomonas vaginalis infection in females attending tertiary care hospital of North India.
    Khatoon R; Jahan N; Ahmad S; Khan HM; Rabbani T
    Indian J Pathol Microbiol; 2015; 58(1):36-9. PubMed ID: 25673589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of symptomatic and asymptomatic Trichomonas vaginalis infection by applying one tube nested PCR to vaginal discharge.
    Mahmoud MS; Abdel-Aziz SS; El-Sherif EA; Swidan KH
    J Egypt Soc Parasitol; 1999; 29(3):1031-46. PubMed ID: 12561939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Survival of Trichomonas vaginalis in the environmental media].
    Hued NI; Casero RD
    Rev Argent Microbiol; 2003; 35(2):113-5. PubMed ID: 12920996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of Trichomonas vaginalis detected in Papanicolaou smear: a survey in female Social Hygiene Clinic.
    Loo SK; Tang WY; Lo KK
    Hong Kong Med J; 2009 Apr; 15(2):90-3. PubMed ID: 19342733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevalence of Trichomonas vaginalis Donné in women of Lódź population in 1955-1999 years].
    Kurnatowska A; Mamos AR
    Wiad Parazytol; 2001; 47 Suppl 1():9-12. PubMed ID: 16897945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response.
    Yadav M; Gupta I; Malla N
    Parasite Immunol; 2005 Dec; 27(12):461-7. PubMed ID: 16255745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vulvovaginal trichomoniasis: epidemiology, clinical and parasitological characteristics].
    Aloui D; Trabelsi S; Bouchekoua M; Khaled S
    Tunis Med; 2015 Jun; 93(6):376-80. PubMed ID: 26644101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.
    Konje JC; Otolorin EO; Ogunniyi JO; Obisesan KA; Ladipo OA
    Afr J Med Med Sci; 1991 Mar; 20(1):29-34. PubMed ID: 1905467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.
    Mavedzenge SN; Pol BV; Cheng H; Montgomery ET; Blanchard K; de Bruyn G; Ramjee G; Straten Av
    Sex Transm Dis; 2010 Jul; 37(7):460-6. PubMed ID: 20562586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of Trichomonas vaginalis infection in symptomatic and asymptomatic women in Central Vietnam.
    Ton Nu PA; Nguyen VQ; Cao NT; Dessì D; Rappelli P; Fiori PL
    J Infect Dev Ctries; 2015 Jul; 9(6):655-60. PubMed ID: 26142677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of cytological and parasitological methods in the diagnosis of Trichomonas vaginalis.
    Karaman U; Karadağ N; Atambay M; Arserim Kaya NB; Daldal NU
    Turkiye Parazitol Derg; 2008; 32(4):309-12. PubMed ID: 19156601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.